Clinical Trials Browser

Interventional × Gastrointestinal Neoplasms × Standard of Care × Clear all

Gastrointestinal Neoplasms

NCT05038254 2025-08-12

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT06562348 2025-05-01

ctDNA-RECIST

Phase 2 Recruiting

167 enrolled

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasm Metastasis

NCT03329690 2022-03-18

DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]

Phase 2 Completed

233 enrolled 26 charts 1 FDA

Gastrointestinal

Adenocarcinoma, Gastrointestinal Neoplasms

NCT01160367 2018-09-05

Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life

Phase NA Completed

431 enrolled

Gastrointestinal

Amyotrophic Lateral Sclerosis, Gastrointestinal Neoplasms, Pancreatic Neoplasms

NCT01200316 2017-11-30

Rocking Motion: Physiologic Effect on the Surgical Stress Response

Phase 1 Completed

86 enrolled

Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms

Clinical Trials

Perioperative Telemonitoring to Optimize Cancer Care and Outcomes

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

ctDNA-RECIST

DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]

Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life

Rocking Motion: Physiologic Effect on the Surgical Stress Response